Sensei Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2,846 | $0 |
Gross Profit | -135 | -137 | 2,711 | -455 |
EBITDA | -7,652 | -8,593 | -8,007 | -7,737 |
EBIT | -7,787 | -8,730 | -8,142 | -8,192 |
Net Income | -7,142 | -7,992 | -7,414 | -7,124 |
Net Change In Cash | 0 | 0 | 2,846 | 0 |
Free Cash Flow | -5,901 | -7,653 | -6,163 | -4,661 |
Cash | 11,891 | 10,956 | 13,011 | 11,343 |
Basic Shares | 25,104 | 25,049 | 25,030 | 25,514 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -571 | -1,808 | -685 | -209 |
EBITDA | -35,613 | -48,841 | -35,997 | -17,975 |
EBIT | -36,964 | -50,188 | -36,682 | -18,184 |
Net Income | -34,101 | -48,807 | -37,464 | -20,629 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -32,203 | -39,347 | -32,285 | -18,911 |
Cash | 13,011 | 17,795 | 7,159 | 16,596 |
Basic Shares | 27,952 | 30,703 | 27,710 | 30,588 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.28 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.30 |
2023-09-30 | -$0.28 |
